In-vitro and in-vivo studies of resistance to rifampin in meningococci.
D000293:Adolescent; D000328:Adult; D002353:Carrier State / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy* / Q000517:prevention & control; D008826:Microbial Sensitivity Tests; D008887:Military Medicine; D009305:Nasopharynx / Q000382:microbiology; D009345:Neisseria meningitidis / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D010919:Placebos; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use*
D010919:Placebos; D012293:Rifampin